Comparative metabolism of the tobacco-related carcinogens benzo[a]pyrene, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, 4- (methylnitrosamino)-1-(3-pyridyl)-1-butanol, and N'-nitrosonornicotine in human hepatic microsomes

Drug Metabolism and Disposition

Volumn 25, Issue 2, 1997, Pages 154-162

  Staretz, Marianne E ^b   Murphy, Sharon E ^b   Patten, Christopher J ^b   Nunes, Maria G ^b   Koehl, Werner ^b   Amin, Shantu ^b   Koenig, Leeann A ^b   Guengerich, F Peter ^b   Hecht, Stephen S ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANOL; 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; BENZO[A]PYRENE; CARCINOGEN; NITROSONORNICOTINE; TOBACCO SMOKE;

ARTICLE; CHEMICAL ANALYSIS; CHEMICAL COMPOSITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; ISOTOPE LABELING; LIVER MICROSOME METABOLISM; PRIORITY JOURNAL; SMOKING;

BENZO(A)PYRENE; BIOTRANSFORMATION; CARCINOGENS; CYTOCHROME P-450 ENZYME SYSTEM; HUMANS; MICROSOMES, LIVER; NITROSAMINES; PLANTS, TOXIC; TOBACCO;

NICOTIANA TABACUM; TRITIUM;

EID: 0031037572     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. D. Hoffmann and S. S. Hecht: Advances in tobacco carcinogenesis. In "Handbook of Experimental Pharmacology" (C. S. Cooper and P. L. Grover, eds.), pp. 63-102. Springer-Verlag, Heidelberg, 1990.
2. A. Rivenson, D. Hoffmann, B. Prokopczyk, S. Amin, and S. S. Hecht: Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and Areca-derived N-nitrosamines. Cancer Res. 48, 6912-6917 (1988).
3. S. S. Hecht and D. Hoffmann: The relevance of tobacco-specific nitrosamines to human cancer. Cancer Surv. 8, 273-294 (1989).
4. S. S. Hecht, A. Rivenson, J. Braley, J. DiBello, J. D. Adams, and D. Hoffmann: Induction of oral cavity tumors in F344 rats by tobacco-specific nitrosamines and snuff. Cancer Res. 46, 4162-4166 (1986).
5. A. H. Conney: Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G. H. A. Clowes Memorial Lecture. Cancer Res. 42, 4875-4917 (1982).
6. D. R. Thakker, H. Yagi, W. Levin, A. W. Wood, A. H. Conney, and D. M. Jerina: Polycyclic aromatic hydrocarbons: metabolic activation to ultimate carcinogens. In "Bioactivation of Foreign Compounds" (M. W. Anders, ed.), pp. 177-242. Academic Press, New York, 1985.
7. S. S. Hecht: Metabolic activation and detoxification of tobacco-specific nitrosamines - a model for cancer prevention strategies. Drug Metab. Rev. 26, 373-390 (1994).
8. S. S. Hecht: Recent studies on mechanisms of bioactivation and detoxification of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a tobacco-specific lung carcinogen. CRC Crit. Rev. Toxicol. 26, 163-181 (1996).
9. L. A. Peterson, D. K. Ng, R. A. Stearns, and S. S. Hecht: Formation of NADP(H) analogs of tobacco specific nitrosamines in rat liver and pancreatic microsomes. Chem. Res. Toxicol. 7, 599-608 (1994).
10. C. B. Chen, S. S. Hecht, and D. Hoffmann: Metabolic α-hydroxylation of the tobacco specific carcinogen, N′-nitrosonornicotine. Cancer Res. 38, 3639-3645 (1978).
11. T. Shimada, M. V. Martin, D. Pruess-Schwartz, L. J. Marnett, and F. P. Guengerich: Roles of individual human cytochrome P-450 enzymes in the bioactivation of benzo(a)pyrene, 7,8-dihydroxy-7,8-dihydrobenzo-(a)pyrene, and other dihydrodiol derivatives of polycyclic aromatic hydrocarbons. Cancer Res. 49, 6304-6312 (1989).
12. C.-H. Yun, T. Shimada, and F. P. Guengerich: Roles of human liver cytochrome P4502C and 3A enzymes in the 3-hydroxylation of benzo(a)pyrene. Cancer Res. 52, 1868-1874 (1992).
13. E. Bauer, Z. Guo, Y.-F. Ueng, L. C. Bell, D. Zeldin, and F. P. Guengerich: Oxidation of benzo[a]pyrene by recombinant human cytochrome P450 enzymes. Chem. Res. Toxicol. 8, 136-142 (1995).
14. M. Shou, K. R. Korzekwa, C. L. Crespi, F. J. Gonzalez, and H. V. Gelboin: The role of 12 cDNA-expressed human, rodent, and rabbit cytochromes P450 in the metabolism of benzo[a]pyrene and benzo-[a]pyrene trans-7,8-dihydrodiol. Mol. Carcinogenesis 10, 159-168 (1994).
15. S. S. Hecht, C. B. Chen, G. D. McCoy, D. Hoffmann, and L. Domellöf: α-Hydroxylation of N-nitrosopyrrolidine and N′-nitrosonornicotine by human liver microsomes. Cancer Lett. 8, 35-41 (1979).
16. A. Castonguay, G. D. Stoner, H. A. J. Schut, and S. S. Hecht: Metabolism of tobacco-specific N-nitrosamines by cultured human tissues. Proc. Natl. Acad. Sci. U.S.A. 80, 6694-6697 (1983).
17. T. J. Smith, Z. Y. Guo, F. J. Gonzalez, F. P. Guengerich, G. D. Stoner, and C. S. Yang: Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in human lung and liver microsomes and cytochromes P-450 expressed in hepatoma cells. Cancer Res. 52, 1757-1763 (1992).
18. T. J. Smith, G. D. Stoner, and C. S. Yang: Activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human lung microsomes by cytochromes P450, lipoxygenase, and hydroperoxides. Cancer Res. 55, 5566-5573 (1995).
19. T. J. Smith, Z. Quo, F. P. Guengerich, and C. S. Yang: Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by human cytochrome P450 1A2 and its inhibition by phenethyl isothiocyanate. Carcinogenesis 17, 809-813 (1996).
20. C. J. Patten, T. J. Smith, S. E. Murphy, M. Wang, J. Lee, R. E. Tynes, P. Koch, and C. S. Yang: Kinetic analysis of the activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by heterologously expressed human P450 enzymes, and the effect of P450 specific chemical inhibitors on this activation in human liver microsomes. Arch. Biochem. Biophys. 333, 127-138 (1996).
21. C. J. Patten, T. J. Smith, S. E. Murphy, and C. S. Yang: NNN and NNK activation by heterologously expressed human P450s. Proc. Am. Assoc. Cancer Res. 37, 101 (1996).
22. F. P. Guengerich: Analysis and characterization of enzymes. In "Principles and Methods of Toxicology" (A. W. Hayes, ed.), pp. 1259-1313. Raven Press, New York, 1994.
23. S. S. Hecht, R. Young, and C. B. Chen: Metabolism in the F344 rat of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco specific carcinogen. Cancer Res. 40, 4144-4150 (1980).
24. S. S. Hecht, C. B. Chen, M. Dong, R. M. Ornaf, D. Hoffmann, and T. C. Tso: Studies on non-volatile nitrosamines in tobacco. Beitr. Tabakforsch. 9, 1-6 (1977).
25. H. McKennis, S. L. Schwartz, L. B. Turnbull, E. Tamaki, and E. R. Bowman: The metabolic formation of gamma-(3-pyridyl)-gamma-hydroxybutyric acid and its possible intermediary role in the mammalian metabolism of nicotine. J. Biol. Chem. 239, 3981-3989 (1964).
26. A. Castonguay, H. Tjälve, N. Trushin, and S. S. Hecht: Perinatal metabolism of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in C57B1 mice. J. Natl. Cancer Inst. 72, 1117-1126 (1984).
27. S. E. Murphy and D. A. Spina: Evidence for a high affinity enzyme in rat esophageal microsomes which alpha-hydroxylates N′-nitrosonornicotine. Carcinogenesis 15, 2709-2713 (1994).
28. W. Koehl, S. Amin, M. E. Staretz, Y.-F. Ueng, H. Yamazaki, T. Tateishi, F. P. Guengerich, and S. S. Hecht: Metabolism of 5-methylchrysene and 6-methylchrysene by human hepatic and pulmonary cytochrome P450 enzymes. Cancer Res. 56, 316-324 (1996).
29. L. A. Peterson, R. Mathew, and S. S. Hecht: Quantitation of metabolic α-hydroxylation of the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res. 51, 5495-5500 (1991).
30. S. E. Murphy, D. A. Spina, M. G. Nunes, and D. A. Pullo: Glucuronidation of 4-(hydroxymethyl)nitrosamino-1-(3-pyridyl)-1-butanone, a metabolically activated form of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, by phenobarbital treated rats. Chem. Res. Toxicol. 8, 772-779 (1995).
31. G. L. Ginsberg and T. B. Atherholt: DNA adduct formation in mouse tissues in relation to serum levels of benzo(a)pyrene-diol-epoxides after injection of benzo(a)pyrene or the diol-epoxide. Cancer Res. 50, 1189-1194 (1990).
32. S. S. Hecht and D. Lin: Comparative mutagenicity of 4-(carbethoxynitrosamino)-4-(3-pyridyl)butanal and 4-(carbethoxynitrosamino)-1-(3-pyridyl)-1-butanone, model compounds for α-hydroxylation of N′-nitrosonornicotine. Carcinogenesis 7, 611-614 (1986).
33. N. Trushin, A. Rivenson, and S. S. Hecht: Evidence supporting the role of DNA pyridyloxobutylation in rat nasal carcinogenesis by tobacco specific nitrosamines. Cancer Res. 54, 1205-1211 (1994).
34. S. E. Murphy, R. Heiblum, and N. Trushin: Comparative metabolism of N′-nitrosonomicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by cultured rat oral tissue and esophagus. Cancer Res. 50, 4685-4691 (1990).
35. 6-methylguanine formation in Clara cells and induction of pulmonary neoplasia in the rat by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res. 50, 3772-3780 (1990).
36. M. E. Staretz, P. G. Foiles, L. Miglietta, and S. S. Hecht: Effects of phenethyl isothiocyanate on DNA adducts in whole lung and lung cell types of rats exposed to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Proc. Am. Assoc. Cancer Res. 37, 266 (1996).
37. 6-Methylguanine is a critical determinant of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone tumorigenesis in A/J mouse lung. Cancer Res. 51, 5557-5564 (1991).
38. H. F. Tiano, M. Hosokawa, P. C. Chulada, P. B. Smith, R.-L. Wang, F. J. Gonzalez, C. L. Crespi, and R. Langenbach: Retroviral mediated expression of human cytochrome P450 2A6 in C3H/10T1/2 cells confers transformability by 4-(methylnitrosamino)-1-(3-Pyridyl)-1-butanone (NNK). Carcinogenesis 14, 1421-1427 (1993).
39. J. D. Adams, E. J. LaVoie, and D. Hoffmann: On the pharmacokinetics of tobacco-specific N-nitrosamines in Fischer rats. Carcinogenesis 6, 509-511 (1985).
40. J. D. Adams, E. J. LaVoie, K. J. O'Mara-Adams, D. Hoffmann, K. D. Carey, and M. V. Marshall: Pharmacokinetics of N′-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in laboratory animals. Cancer Lett. 28, 195-201 (1985).
41. S. S. Hecht, N. Trushin, C. A. Reid-Quinn, E. S. Burak, A. B. Jones, J. L. Southers, C. T. Gombar, S. G. Carmella, L. M. Anderson, and J. M. Rice: Metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the Patas monkey: pharmacokinetics and characterization of glucuronide metabolites. Carcinogenesis 14, 229-236 (1993).
42. S. S. Hecht and N. Trushin: DNA and hemoglobin alkylation by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and its major metabolite 4-(methynitrosamino)-1-(3-pyridyl)-1-butanol in F344 rats. Carcinogenesis 9, 1665-1668 (1988).
43. K. R. Kaderlik and F. F. Kadlubar: Metabolic polymorphisms and carcinogen-DNA adduct formation in human populations. Pharmacogenetics 5, S108-S117 (1995).
44. A. Pelkonen, E. H. Kaltiala, N. T. Karki, K. Jalonen, and K. Pyorala: Properties of benzpyrene hydroxylase from human liver and comparison with the rat, rabbit, and guinea pig enzymes. Xenobionca 5, 501-509 (1975).
45. H. Yamazaki, Y. Inui, C.-H. Yun, F. P. Guengerich, T. Shimada: Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes. Carcinogenesis 13, 1789-1794 (1992).